OTC Markets · Medical Devices · USD
Vicarious Surgical Inc. (RBOT) Stock Analysis
Vicarious Surgical Inc. (RBOT) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.
Last Updated: October 20, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
RBOT Key Statistics
As of Oct 20, 2026Trading
- Open
- $0.001
- Previous Close
- $0.02
- Day's Range
- 0.001–0.26
- 52-Week Range
- 0.001–6.28
- Volume
- 39.70K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 2.16
Valuation
- Market Cap
- $7.13K
- P/E Ratio
- unprofitable
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −6.63
Financials (FY)
- Revenue (FY)
- $0.00
- Net Income (FY)
- −$50.18M
- Shares Outstanding
- 6.48M
- 1-Year Return
- −99.98%
Dividend and dates
- Avg Volume
- 45.11K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 20, 2026, RBOT closed at $0.001, −99.98% over 1 year.
Vicarious Surgical Inc. (RBOT) has a market capitalization of $7.13K.
In fiscal 2025, RBOT reported revenue of $0.00.
RBOT Stock Return by Calendar Year
Vicarious Surgical Inc. (RBOT) return since Sep 2020: what $10,000 became
- 1 year
- $10,000 $2
- −99.98%
- 5 years
- $10,000 $0.03
- −99.9997%
- Since Sep 2020
- $10,000 $0.03
- −99.9997%
If you had invested $10,000 in Vicarious Surgical Inc. (RBOT) at the close on September 4, 2020, the earliest close on record here, it would have been worth $0.03 at the close on October 20, 2026: −99.9997% in total, −87.19% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −99.95% |
| 2025 | −83.51% |
| 2024 | +19.53% |
| 2023 | −81.83% |
| 2022 | −80.98% |
| 2021 | +4.53% |
| 2020 (partial year) | +4.21% |
As of October 20, 2026.
RBOT Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $0.00 | −$50.18M | — |
| 2024 | $0.00 | −$63.22M | — |
| 2023 | $0.00 | −$71.07M | — |
| 2022 | $0.00 | $5.16M | — |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $0.00 | — | −$50.97M | −$50.18M | — |
| 2024 | $0.00 | — | −$66.56M | −$63.22M | — |
| 2023 | $0.00 | — | −$80.67M | −$71.07M | — |
| 2022 | $0.00 | — | −$80.08M | $5.16M | — |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$173.92B
MDTMedtronic plc.
$119.00B
SYKStryker Corporation
$114.15B
BSXBoston Scientific Corporation
$64.33B
EWEdwards Lifesciences Corporation
$50.95B
GEHCGE HealthCare Technologies Inc.
$31.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B